Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
NCT07672262 Venetoclax Acute Myeloid Leukemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
A focused 2026 clinical landscape deep dive into NCT07672262, evaluating Venetoclax in Acute Myeloid Leukemia: trial design, endpoint strategy, sponsor context, benchmark readouts and development white space.
Latest Hotspot
8 min read
NCT07671378 Sonrotoclax Chronic Lymphocytic Leukemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
A focused 2026 clinical landscape deep dive into NCT07671378, evaluating Sonrotoclax in Chronic Lymphocytic Leukemia: trial design, endpoint strategy, sponsor context, benchmark readouts and development white space.
Latest Hotspot
8 min read
NCT07670065 Direct Angio Suite Acute Stroke Intervention With CT/DSA Hybrid Emergency Stroke Unit Acute Ischemic Stroke Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout
21 July 2026
A focused 2026 clinical landscape deep dive into NCT07670065, evaluating Direct Angio Suite Acute Stroke Intervention With CT/DSA Hybrid Emergency Stroke Unit in Acute Ischemic Stroke: trial design, endpoint strategy, sponsor context, benchmark readouts and development white space.
Latest Hotspot
8 min read
CTR20262307 Xiyue Shanhua oil Spray Burns Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
A focused 2026 clinical landscape deep dive into CTR20262307, evaluating Xiyue Shanhua oil Spray in Burns: trial design, endpoint strategy, sponsor context, benchmark readouts and development white space.
Latest Hotspot
8 min read
NCT07671924 Nalbuphine Hydrochloride Refractory chronic cough Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
A focused 2026 clinical landscape deep dive into NCT07671924, evaluating Nalbuphine Hydrochloride in Refractory chronic cough: trial design, endpoint strategy, sponsor context, benchmark readouts and development white space.
Latest Hotspot
8 min read
NCT07670507 Ketamine Hydrochloride Nociceptive Pain Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
A focused 2026 clinical landscape deep dive into NCT07670507, evaluating Ketamine Hydrochloride in Nociceptive Pain: trial design, endpoint strategy, sponsor context, benchmark readouts and development white space.
Latest Hotspot
8 min read
NCT07672223 Enlonstobart Non-small cell lung cancer stage IIIB Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
A focused 2026 clinical landscape deep dive into NCT07672223, evaluating Enlonstobart in Non-small cell lung cancer stage IIIB: trial design, endpoint strategy, sponsor context, benchmark readouts and development white space.
Latest Hotspot
8 min read
JPRN-jRCT2031260207 Foscenvivint Hemophilia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
A focused 2026 clinical landscape deep dive into JPRN-jRCT2031260207, evaluating Foscenvivint in Hemophilia: trial design, endpoint strategy, sponsor context, benchmark readouts and development white space.
Latest Hotspot
8 min read
NCT07671001 Depemokimab Asthma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
A focused 2026 clinical landscape deep dive into NCT07671001, evaluating Depemokimab in Asthma: trial design, endpoint strategy, sponsor context, benchmark readouts and development white space.
Latest Hotspot
8 min read
NCT07671911 Nalbuphine Hydrochloride Idiopathic Pulmonary Fibrosis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
A focused 2026 clinical landscape deep dive into NCT07671911, evaluating Nalbuphine Hydrochloride in Idiopathic Pulmonary Fibrosis: trial design, endpoint strategy, sponsor context, benchmark readouts and development white space.
Latest Hotspot
8 min read
NCT07671287 Lenalidomide Multiple Myeloma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
A focused 2026 clinical landscape deep dive into NCT07671287, evaluating Lenalidomide in Multiple Myeloma: trial design, endpoint strategy, sponsor context, benchmark readouts and development white space.
Latest Hotspot
8 min read
ChiCTR2600127200 Trastuzumab Rezetecan Locally advanced breast cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
A focused 2026 clinical landscape deep dive into ChiCTR2600127200, evaluating Trastuzumab Rezetecan in Locally advanced breast cancer: trial design, endpoint strategy, sponsor context, benchmark readouts and development white space.